FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4309277434> ?p ?o ?g. }

• W4309277434 endingPage "296" @default.
• W4309277434 startingPage "290" @default.
• W4309277434 abstract "The Biologic Abatement and Capturing Kids' Outcomes and Flare Frequency in Juvenile Spondyloarthritis (BACK-OFF JSpA) study is a randomized, pragmatic trial investigating different tumour necrosis factor inhibitor de-escalation strategies for children with sustained inactive disease. In this project, we elicited concept rankings that aided in the selection of the patient-reported outcome (PRO) measures that should be examined as part of the BACK-OFF JSpA trial.We conducted a discrete choice experiment to evaluate individuals' preferences regarding PROs. Stakeholders assessed a discrete list of 21 outcome concepts, each of which had a Patient-Reported Outcome Measurement Information System (PROMIS) measure associated with it. PROMIS measures are self- or proxy-reported instruments that are universally applicable to the general population and all chronic conditions. Stakeholders were required to make choices instead of expressing the strength of a preference.Fourteen caregivers, 12 patients (9-22 years old), 16 rheumatologists and three executives from health insurance companies completed the exercise, which took approximately 10 min. The discrete choice experiment resulted in an estimate of the relative importance of each outcome and rank. All stakeholder groups agreed that the primary PRO should be 'Pain Interference', a measure that evaluates the effect of pain on a child's everyday activities, including its impact on social, emotional, mental and physical functioning. Patients and caregivers were mostly aligned in their top priorities, with patients valuing physical health (50% of the top 10) whereas caregivers were more interested in mental health (60% of the top 10). Rheumatologists and health insurance executives were most interested in physical health outcomes, which were ranked 80% and 60% of their top 10 PROs, respectively. Overall, the patients had the most diverse set of prioritized outcomes, including at least one of each category in their top 10 rank order of importance. Patients were also the only stakeholders to prioritize 'social' health.Patients and caregivers were mostly aligned in their outcome priority rankings. The rank-order list directly informed the creation of a profile of PRO measures for our upcoming trial.Stakeholder partners helped with acquisition of data and lead parent partners helped interpret data." @default.
• W4309277434 created "2022-11-25" @default.
• W4309277434 creator A5000386688 @default.
• W4309277434 creator A5003475399 @default.
• W4309277434 creator A5005348970 @default.
• W4309277434 creator A5005581198 @default.
• W4309277434 creator A5019345424 @default.
• W4309277434 creator A5019645589 @default.
• W4309277434 creator A5037471312 @default.
• W4309277434 creator A5037637158 @default.
• W4309277434 creator A5038713763 @default.
• W4309277434 creator A5039216528 @default.
• W4309277434 creator A5042422193 @default.
• W4309277434 creator A5043731720 @default.
• W4309277434 creator A5052945062 @default.
• W4309277434 creator A5057327851 @default.
• W4309277434 creator A5058640631 @default.
• W4309277434 creator A5063327330 @default.
• W4309277434 creator A5064198651 @default.
• W4309277434 creator A5075706147 @default.
• W4309277434 creator A5090835696 @default.
• W4309277434 creator A5091401834 @default.
• W4309277434 date "2022-11-17" @default.
• W4309277434 modified "2023-10-16" @default.
• W4309277434 title "Stakeholder outcome prioritization in the Biologic Abatement and Capturing Kids' Outcomes and Flare Frequency in Juvenile Spondyloarthritis (BACK‐OFF JSpA) trial" @default.
• W4309277434 cites W2101716521 @default.
• W4309277434 cites W2138181327 @default.
• W4309277434 cites W2138871559 @default.
• W4309277434 cites W2140828104 @default.
• W4309277434 cites W2328780927 @default.
• W4309277434 cites W2360305338 @default.
• W4309277434 cites W2797862713 @default.
• W4309277434 cites W2909964264 @default.
• W4309277434 cites W2913547994 @default.
• W4309277434 cites W2997884561 @default.
• W4309277434 cites W3005579845 @default.
• W4309277434 cites W3124648158 @default.
• W4309277434 cites W4309277434 @default.
• W4309277434 doi "https://doi.org/10.1111/hex.13655" @default.
• W4309277434 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36398414" @default.
• W4309277434 hasPublicationYear "2022" @default.
• W4309277434 type Work @default.
• W4309277434 citedByCount "2" @default.
• W4309277434 countsByYear W43092774342022 @default.
• W4309277434 countsByYear W43092774342023 @default.
• W4309277434 crossrefType "journal-article" @default.
• W4309277434 hasAuthorship W4309277434A5000386688 @default.
• W4309277434 hasAuthorship W4309277434A5003475399 @default.
• W4309277434 hasAuthorship W4309277434A5005348970 @default.
• W4309277434 hasAuthorship W4309277434A5005581198 @default.
• W4309277434 hasAuthorship W4309277434A5019345424 @default.
• W4309277434 hasAuthorship W4309277434A5019645589 @default.
• W4309277434 hasAuthorship W4309277434A5037471312 @default.
• W4309277434 hasAuthorship W4309277434A5037637158 @default.
• W4309277434 hasAuthorship W4309277434A5038713763 @default.
• W4309277434 hasAuthorship W4309277434A5039216528 @default.
• W4309277434 hasAuthorship W4309277434A5042422193 @default.
• W4309277434 hasAuthorship W4309277434A5043731720 @default.
• W4309277434 hasAuthorship W4309277434A5052945062 @default.
• W4309277434 hasAuthorship W4309277434A5057327851 @default.
• W4309277434 hasAuthorship W4309277434A5058640631 @default.
• W4309277434 hasAuthorship W4309277434A5063327330 @default.
• W4309277434 hasAuthorship W4309277434A5064198651 @default.
• W4309277434 hasAuthorship W4309277434A5075706147 @default.
• W4309277434 hasAuthorship W4309277434A5090835696 @default.
• W4309277434 hasAuthorship W4309277434A5091401834 @default.
• W4309277434 hasBestOaLocation W43092774341 @default.
• W4309277434 hasConcept C118552586 @default.
• W4309277434 hasConcept C119857082 @default.
• W4309277434 hasConcept C126322002 @default.
• W4309277434 hasConcept C134362201 @default.
• W4309277434 hasConcept C15744967 @default.
• W4309277434 hasConcept C168563851 @default.
• W4309277434 hasConcept C1862650 @default.
• W4309277434 hasConcept C2780148112 @default.
• W4309277434 hasConcept C2908647359 @default.
• W4309277434 hasConcept C41008148 @default.
• W4309277434 hasConcept C512399662 @default.
• W4309277434 hasConcept C71924100 @default.
• W4309277434 hasConcept C99454951 @default.
• W4309277434 hasConceptScore W4309277434C118552586 @default.
• W4309277434 hasConceptScore W4309277434C119857082 @default.
• W4309277434 hasConceptScore W4309277434C126322002 @default.
• W4309277434 hasConceptScore W4309277434C134362201 @default.
• W4309277434 hasConceptScore W4309277434C15744967 @default.
• W4309277434 hasConceptScore W4309277434C168563851 @default.
• W4309277434 hasConceptScore W4309277434C1862650 @default.
• W4309277434 hasConceptScore W4309277434C2780148112 @default.
• W4309277434 hasConceptScore W4309277434C2908647359 @default.
• W4309277434 hasConceptScore W4309277434C41008148 @default.
• W4309277434 hasConceptScore W4309277434C512399662 @default.
• W4309277434 hasConceptScore W4309277434C71924100 @default.
• W4309277434 hasConceptScore W4309277434C99454951 @default.
• W4309277434 hasIssue "1" @default.
• W4309277434 hasLocation W43092774341 @default.
• W4309277434 hasLocation W43092774342 @default.
• W4309277434 hasLocation W43092774343 @default.
• W4309277434 hasOpenAccess W4309277434 @default.

• next